Acuitas Lipid III-25
Acuitas Lipid III-25 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent US 10,166,298 B2, with pKa 6.22, Liver Luc 1648 for 0.3mgkg (ng luc/g liver), Liver Luc 13880 for 1mgkg (ng luc/g liver) . It is an analgous of ALC-0315, showing higher activity than ALC-0315.
Product Specifications
CAS Number
2036273-14-8
Field of Research
Metabolism Research
Purity
>95%
Smiles
O (C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) N (C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) O[H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) OC (C ([H]) (C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) [H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) [H]) =O) C (C ([H]) (C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) [H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) [H]) =O
Molecular Formula
C46H91NO5
Molecular Weight
738.2
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog